How to Reduce Taxes When Selling a Business: 7 Strategies for 2026

Structural choices made before and during a business sale can mean a 10–30% difference in what you keep. Most of the best strategies require planning well ahead of closing — often 2–5 years. Here's what actually moves the number.

Strategy 1: Qualify your stock for QSBS exclusion (Section 1202)

The single most powerful business-exit tax benefit in the code. Under IRC § 1202, gain from the sale of qualified small business stock (QSBS) can be partially or entirely excluded from federal capital gains tax.¹

How it works under 2026 rules (post-OBBBA):

• Eligible stock: original-issue C-corporation stock, acquired directly from the company (not secondary), in a qualifying trade or business, with company gross assets under $75M at time of issuance (for stock issued after July 4, 2025) or under $50M (for stock issued on or before July 4, 2025).²
• Exclusion cap: the greater of $15M or 10× your adjusted basis per taxpayer (for post-OBBBA stock); the greater of $10M or 10× basis for pre-OBBBA stock.²
• Holding period — post-OBBBA tiered: 3 years = 50% exclusion; 4 years = 75%; 5 years = 100%. Pre-OBBBA stock requires the full 5-year hold for any exclusion.
• Federal tax on excluded gain: $0. The excluded portion doesn't enter the capital gains calculation at all.

On a $15M sale with $500K basis, a founder who qualifies for 100% QSBS exclusion pays zero federal capital gains on the first $15M of gain — a $3.5M+ federal tax savings versus a straight LTCG sale.

Key requirements to act on now:

• Must be a C-corporation. LLCs and S-corps don't qualify. S→C conversions can start a new QSBS clock, but require careful planning around the built-in gains period.
• Must hold for at least 3 years (post-OBBBA for partial exclusion) or 5 years (pre-OBBBA). Start the clock early — you can't accelerate it once negotiations begin.
• Must be a stock sale. Asset sales don't qualify for QSBS treatment, regardless of how the purchase agreement allocates proceeds.

For the full technical treatment: QSBS Section 1202 guide. For a quick estimate: QSBS exclusion calculator.

Strategy 2: Structure the sale as a stock sale, not an asset sale

The deal structure — stock sale vs. asset sale — determines how each dollar of proceeds is taxed. The difference can be 5–15% of total sale price.

• Stock sale: you sell your shares. Proceeds are almost entirely capital gains (federal top rate 23.8% including NIIT³). QSBS exclusion applies. Clean exit — buyer assumes all corporate liabilities.
• Asset sale: the company sells its underlying assets. Some asset classes — particularly equipment with depreciation history, and non-compete agreements — generate ordinary income at up to 37%. Only goodwill, going-concern value, and certain other intangibles receive capital gain treatment. Buyer gets a step-up in basis, which they value; seller pays the higher rate, which you pay.

The tax gap on a $10M sale with $2M of depreciation recapture and $1M allocated to a non-compete could easily be $400K–$700K in additional tax compared to a clean stock sale.

Buyers usually prefer asset sales (they want the step-up). The seller's job is to negotiate — either hold out for stock sale, or negotiate a purchase price premium that offsets the tax disadvantage of asset sale treatment. Understanding the exact gap is how you know what to ask for.

S-corp owners have a middle path: the § 338(h)(10) election, which allows a stock sale to be treated as an asset sale for the buyer (they get the step-up) while the seller gets stock sale economics for state law purposes. This doesn't fully solve the ordinary income problem but can be useful in specific situations.

Full analysis: Asset sale vs. stock sale guide. To model the numbers: Asset vs. stock sale calculator.

Strategy 3: Installment sale — spread the gain across years (IRC § 453)

If the buyer pays you over time rather than all at close, you can elect installment treatment under IRC § 453: report your gain proportionally as you receive payments, rather than recognizing everything in year one.⁴

When this works well:

• Your business basis is very low and a single-year recognition would create an outsized income spike.
• You expect lower income in future years (you're stepping back post-sale), so spreading gain keeps you out of the highest brackets.
• The buyer is financing part of the purchase with a seller note anyway — the installment structure is already built in.

The depreciation recapture trap: Under § 453(i), all depreciation recapture is recognized in the year of sale regardless of when you receive payment. If your business has significant equipment with accumulated depreciation, the installment method helps only on the gain in excess of recapture. Run the calculation before designing the structure.

§ 453A interest charge: If your total outstanding installment receivables exceed $5M, you owe an annual interest charge to the IRS on the deferred tax — approximately 6% of the deferred tax attributable to the balance above $5M (Q2 2026 rate). This can meaningfully reduce the benefit of deferral for very large deals.

Full analysis and scenarios: Installment sale strategy guide. Interactive model: Installment sale calculator.

Strategy 4: Charitable Remainder Trust (CRT) before the sale

A Charitable Remainder Trust (IRC § 664) is a tax-exempt trust: you contribute appreciated stock before the sale, the trust sells tax-free, reinvests the full pre-tax proceeds, and pays you an income stream for life (or a term of years). At the end, the remaining assets go to charity.⁵

The economics on a $3M contribution with $100K basis:

• Direct sale: $2.9M gain × 23.8% = $690K federal tax. You invest approximately $2.31M.
• CRT route: trust sells, recognizes no tax. Full $3M reinvested. You receive income on $3M — a 30% larger principal base generating your lifetime income stream.
• You also get an upfront charitable deduction based on the actuarial present value of the remainder interest (using the § 7520 rate of 5.0% for May 2026⁶).

The binding commitment rule: The CRT must be funded before the sale is final — specifically, before you have a binding commitment to sell the shares. A signed LOI doesn't always trigger this, but it's a fact-specific determination. Don't fund the CRT after the deal is in writing; get your advisor involved before you sign anything.

The tradeoff: you're giving away the remainder. CRT works best when charitable giving is already part of your plan, not as a pure tax play. Full guide: Charitable Remainder Trust guide.

Strategy 5: Pre-sale estate planning — transfer wealth before the close

The value of your business is at its peak just before a sale. If you've been meaning to do estate planning, this is the window — and it closes when the LOI is signed.

Three tools worth knowing:

• GRAT (Grantor Retained Annuity Trust): You transfer business stock to the trust and receive back a fixed annuity for a term of years. The annuity is set so the IRS expects the trust to return exactly what you put in (using the § 7520 hurdle rate of 5.0% for May 2026⁶). If the business grows faster than 5% per year during the GRAT term, the excess passes to heirs gift-tax free. "Zeroed-out" GRATs are a standard tool for transferring pre-exit appreciation.
• IDGT installment sale: You sell business stock to an irrevocable grantor trust in exchange for a promissory note at the mid-term AFR (4.08% for May 2026). No capital gains on the sale to the trust (it's a grantor trust — same taxpayer as you for income tax purposes under Rev. Rul. 85-13). Future appreciation on the stock accrues inside the trust, outside your taxable estate.
• Direct gifting: $19,000 annual exclusion per recipient in 2026; $15M lifetime exemption (made permanent by OBBBA). Gifting stock pre-sale locks in a lower value for gift tax purposes; post-sale, you're gifting cash at known value.

All three windows close or become far less effective once the deal is announced or the LOI is signed. Act 12–24 months before expected close. Full guide: Estate planning before a business sale.

Strategy 6: ESOP — 100% capital gains deferral for C-corp owners (§ 1042)

This one is unique to C-corporation owners. If you sell at least 30% of your C-corp to an Employee Stock Ownership Plan (ESOP) and reinvest the proceeds into domestic operating company stocks or bonds (qualified replacement property, or QRP), you can defer 100% of the capital gains under IRC § 1042.⁷ Hold the QRP until death and the step-up in basis eliminates the gain permanently.

This is the only exit structure where you can completely eliminate capital gains tax — not defer, eliminate.

The tradeoffs:

• You need a C-corp. S-corp owners can sell to an ESOP but don't get § 1042 treatment (they get different but also significant S-corp ESOP tax benefits).
• The ESOP becomes your controlling shareholder. If legacy and employee ownership matter, this is attractive. If you want a clean break with maximum cash, it may not be.
• Leveraged ESOPs typically involve a bank loan (20–40% of purchase price) plus a seller note (60–80%), with repayment from business cash flows. This is a structured transaction requiring M&A counsel and ESOP advisors.

For businesses with strong cash flow and owners who care about the employee legacy: this warrants serious analysis. Full guide: ESOP exit strategy guide.

Strategy 7: Manage asset allocation and deal structure at closing

Even after the headline price is set, ordinary income traps in the deal structure can cost you hundreds of thousands. Two places to focus:

Non-compete agreement allocation. In an asset sale, the IRS treats non-compete payments as ordinary income — taxed at up to 37%.⁸ Goodwill is capital gain at 23.8%. A $1M non-compete vs. $1M goodwill allocation = $132,000 difference in federal tax per million. Buyers are largely indifferent between Class VI (non-compete) and Class VII (goodwill) allocations because both are 15-year amortizable intangibles. You have negotiating room. Use it.

Earnout structuring. Earnout payments can be ordinary income or capital gains depending on how they're structured. IRC § 453 provides a framework for contingent payment treatment, but the characterization depends on the deal documents. Improperly drafted earnouts that look like compensation for post-close services — or consulting agreements that substitute for earnout — are characterized as ordinary income. Get this right before you sign. Full guide: Earnout agreements guide.

Related: Non-compete agreement guide.

How these strategies work together

These aren't mutually exclusive. The most efficient exit plans layer them:

• QSBS + installment sale: if your gain exceeds the $15M QSBS cap, use installment treatment on the excess above the cap. The excluded portion doesn't generate any payment-year recognition; the installment treatment only applies to the taxable remainder.
• QSBS stacking + GRAT: fund GRATs with C-corp stock 4–5 years before exit to move shares (and their future QSBS exclusion) to heirs. Each trust holds QSBS stock with its own $15M cap. Requires 5+ years of lead time.
• CRT + QSBS overflow: if only part of your gain is QSBS-eligible (e.g., mixed stock issuance dates), a CRT funded with non-QSBS shares handles the non-qualified portion.
• Stock sale + estate planning: negotiate the deal as a stock sale to preserve LTCG treatment, simultaneously gift stock via IDGT before the LOI to transfer pre-sale appreciation.

What a fee-only exit-planning specialist actually does

An investment banker optimizes for the headline price. An M&A attorney optimizes for legal structure. A CPA often reviews taxes after the year closes. The gap in the room is a financial planner who models the after-tax outcome of each structural choice before negotiations begin — and who has no incentive to rush the deal.

A fee-only advisor who specializes in business exits will:

• Model QSBS eligibility and whether entity restructuring is worth it at your stage
• Run installment sale scenarios against lump-sum alternatives accounting for state taxes
• Quantify CRT, GRAT, and IDGT outcomes before and after the binding commitment window
• Review asset allocation in the purchase agreement before you sign
• Construct the post-sale portfolio from concentrated-to-diversified with tax efficiency

If you're within 5 years of a planned exit, the conversation starts now — not after the LOI arrives.

Sources

1. IRC § 1202 — Partial Exclusion for Gain from Certain Small Business Stock (LII / Cornell Law). Qualification, exclusion percentages, and asset ceiling.
2. One Big Beautiful Bill Act (OBBBA), enacted July 2025. Raised QSBS exclusion cap to $15M / 10× basis; raised asset ceiling to $75M for post-July 4, 2025 stock; established tiered 50/75/100% exclusion at 3/4/5-year hold for new stock.
3. IRS Topic 559 — Net Investment Income Tax. 3.8% NIIT applies to net investment income including capital gains for single filers above $200K / MFJ above $250K. Combined with 20% LTCG rate = 23.8% top federal rate.
4. IRC § 453 — Installment Method (LII / Cornell Law). Gross profit ratio, § 453(i) recapture acceleration, § 453A interest charge, § 453(k) prohibition on publicly-traded stock.
5. IRC § 664 — Charitable Remainder Trusts (LII / Cornell Law). Tax-exempt treatment, CRUT/CRAT mechanics, distribution rules.
6. Rev. Rul. 2026-09 — § 7520 Rate, May 2026. § 7520 rate 5.0% for May 2026; used for GRAT annuity calculations and CRT remainder valuations.
7. IRC § 1042 — Sales of Stock to Employee Stock Ownership Plans (LII / Cornell Law). C-corp owners selling ≥30% to ESOP can defer 100% of capital gains by reinvesting in qualified replacement property (QRP).
8. IRS Publication 544 — Sales and Other Dispositions of Assets. Non-compete agreements are Class VI intangibles; consideration allocated to them is ordinary income. Goodwill is Class VII; treated as capital gain in most asset sales.

Tax rates and thresholds verified as of May 2026. QSBS rules reflect OBBBA changes effective July 4, 2025. Estate and gift exemption ($15M) reflects OBBBA permanent extension. § 7520 rate (5.0%) and AFR (4.08% mid-term) current as of May 2026. All strategies involve complex legal and tax considerations — verify with a qualified advisor for your specific situation.